these. I can envisage a surveillance model in which the veterinary profession and government would be partners in species and expert groups that bring together monitored data and the intelligence for interpretation at the population level. This would collectively provide better identification and understanding of all threats and issues and their impact and will inform management by whoever is best placed to do so.
AS a screening method for detecting herd-level exposure to Schmallenberg virus (SBV), the bulk milk SBV antibody ELISA offered by Biobest Laboratories has proved popular. Results from this test suggest that the majority of herds in England and Wales have been exposed to SBV (Humphries and Burr 2012) . Indeed, veterinary practices local to us have stopped routinely testing bulk milk tank samples as all herds tested have been positive. However, this testing method does not give an indication of the numbers of animals within a herd that have been exposed to the virus.
In this context, we would like to highlight results from the University of Nottingham's 200-head indoor dairy herd. This herd had a positive bulk milk tank test but only a 25 per cent seroprevalence (5/20 animals tested) for SBV. In contrast, seroprevalence in another herd, housed outdoors during the summer, six miles from the university's herd, had 76 per cent seroprevalence (13/17 animals tested).
The seroprevalence rates for the outdoor herd are consistent with those reported in cattle in Belgium (86 per cent) and the Netherlands (70 to 100 per cent) near the epicentre of the SBV outbreak in 2011/12 (Elbers and others 2012, Meroc and others 2012). The results for the indoor herd suggest that the majority of individuals within the herd will remain susceptible to SBV infection during the 2013 midge season. This low seroprevalence may well be due to low midge exposure in indoor environments. This is also suggested by other reports of herds housed indoors with negative SBV bulk milk tank tests in regions with high SBV exposure rates (Case 2013) as well as suggestions made in the Belgian study that indoor housing of youngstock may be associated with the significantly lower seroprevalence seen in animals under two years of age.
With the likely introduction of a vaccine against SBV in 2013, veterinarians and farm managers will be weighing the costs and benefits of vaccinating herds and flocks. Knowledge of a herd's existing seroprevalence will be a critical factor in this analysis. Garnering this information may, however, be restricted by the cost of testing and there is a need to develop cheap pen-side tests for SBV that can be used to help make vaccination decisions for individual farms. 
SURVEILLANCE

Future of surveillance
I WELCOME the letter from Richard Sibley and Peter Orpin (VR, January 26, 2013, vol 172, p 108) , which further raises the future of surveillance and the benefits it provides. The letter provides real-life examples of how data gathered direct from farmers and private veterinary surgeons can be of benefit in understanding a national and regional picture of production and disease trends and their real-time impacts. I support their assertion that surveillance needs to consider wider sources of information than just postmortem examinations and lab diagnostics. The current AHVLA consultation on surveillance seeks to find ways to improve the way we all do surveillance so that we have a better assessment and understanding of threats and can effectively manage these. This needs to be done as a partnership between government and industry, in which we both contribute and can both benefit. Government's need from surveillance is the early detection of new and re-emerging disease. Indeed, for Schmallenberg virus (SBV) this was very effective. Information from our continental neighbours alerted us to this new threat, which was then detected through laboratory surveillance in the south-east of England, probably very shortly after incursion. Additional investigative surveillance was commissioned to ensure that information was available to farmers and their advisers to make informed choices for their businesses. We now know that the virus has spread across England and it is no surprise that antibodies can be detected in many herds. However, I don't think we can assume a direct relationship between the spread of SBV and the production losses described. I would like to caution against ascribing causality without investigation when we know that these clinical signs are not specific to SBV and can be caused by a large variety of diseases and other factors.
As for many endemic diseases, there comes a point when government can no longer add value to control or management. Our purpose is not to directly be a data collator or to monitor all data on livestock ourselves. As Mr Sibley and Mr Oprin describe, there are a number of tools available that help farmers and vets identify health and welfare risks to specific businesses and there are recognised and effective mitigating actions for most of Letters
